Acadia's final take from stock sale tops $170M

The underwriters handling a secondary stock offering for Acadia Healthcare and several of its shareholders have taken on almost 1.6 million extra shares set aside in case investors showed enough interest. The move means Acadia will net $173 million from the sale after expenses. That will take the company a long way toward the $258 million it has said it will pay for two mental health peers, including locally based Behavioral Centers of America. The new shares also will take Acadia's market cap well north of $1 billion less than two years after Chairman and CEO Joey Jacobs and his team took over.